These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24632718)

  • 61. [Theoretical and practical aspects of the therapy of cardiogenic shock in acute myocardial infarct].
    Dimitriu CG; Karassi A; Manu P
    Med Interna (Bucur); 1972 Apr; 24(4):391-9. PubMed ID: 5027785
    [No Abstract]   [Full Text] [Related]  

  • 62. [Shock states during myocardial infarct: treatment of cardiogenic shock with dopamine].
    Andriange M; Calay G; Gach J; Lisin N
    Acta Clin Belg; 1971; 26(5):249-61. PubMed ID: 5161426
    [No Abstract]   [Full Text] [Related]  

  • 63. Vasopressors for acute myocardial infarction complicated by cardiogenic shock.
    Prondzinsky R; Hirsch K; Wachsmuth L; Buerke M; Unverzagt S
    Med Klin Intensivmed Notfmed; 2019 Feb; 114(1):21-29. PubMed ID: 29204662
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of catecholamines in acute myocardial infarction.
    Dixon DW; Loeb HS; Gunnar RM
    Herz; 1979 Oct; 4(5):385-96. PubMed ID: 391685
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of Norepinephrine on Regional Cerebral Oxygenation During Cardiopulmonary Bypass.
    Hagen OA; Høiseth LØ; Roslin A; Landsverk SA; Woldbaek PR; Pripp AH; Hanoa R; Kirkebøen KA
    J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):291-6. PubMed ID: 27013119
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Problem of cardiogenic shock therapy].
    Chazov EI
    Kardiologiia; 1970 Jul; 10(7):5-12. PubMed ID: 4321603
    [No Abstract]   [Full Text] [Related]  

  • 67. How should I treat refractory cardiogenic shock in acute STEMI with multivessel occlusion?
    Achtchi A; Ibrahim AW; Rahman A; Tanveer Rab S; Noc M; Thiele H
    EuroIntervention; 2014 Dec; 10(8):1009-12. PubMed ID: 25244461
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of vasopressor drugs on circulatory dynamics in shock following myocardial infarction.
    Binder MJ
    Am J Cardiol; 1965 Dec; 16(6):834-40. PubMed ID: 5846008
    [No Abstract]   [Full Text] [Related]  

  • 69. [Drug therapy of cardiogenic shock. Improvement in hemodynamics is essential].
    Stiefelhagen P
    Med Monatsschr Pharm; 2010 Aug; 33(8):303-5. PubMed ID: 21189650
    [No Abstract]   [Full Text] [Related]  

  • 70. [Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].
    Flammang D; Sebastien P; Bouvrain Y
    Ann Anesthesiol Fr; 1975 Dec; 16(9):669-72. PubMed ID: 5028
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of increasing mean arterial blood pressure on microcirculation in patients with cardiogenic shock supported by extracorporeal membrane oxygenation.
    Du Z; Jia Z; Wang J; Xing Z; Jiang C; Xu B; Yang X; Yang F; Miao N; Xing J; Wang H; Jia M; Hou X
    Clin Hemorheol Microcirc; 2018; 70(1):27-37. PubMed ID: 27983541
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Use of nitroglycerin in the complex treatment of cardiogenic shock in patients with myocardial infarction].
    Anshelevich IuV; Prutkin AF; Rubin AI; Orlova VP
    Kardiologiia; 1988 Apr; 28(4):87-9. PubMed ID: 3134569
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure.
    Wendon JA; Harrison PM; Keays R; Gimson AE; Alexander GJ; Williams R
    Hepatology; 1992 Jun; 15(6):1067-71. PubMed ID: 1592345
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction.
    Fellner B; Rohla M; Jarai R; Smetana P; Freynhofer MK; Egger F; Zorn G; Weiss TW; Huber K; Geppert A
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):348-358. PubMed ID: 26936869
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiogenic shock. Recent advances in pharmacologic management. II.
    Kones RJ
    N Y State J Med; 1973 Aug; 73(15):1967-80. PubMed ID: 4354585
    [No Abstract]   [Full Text] [Related]  

  • 76. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
    Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
    Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vasopressor Load: Sounding the Alarm in Management of Cardiogenic Shock Associated With Acute Myocardial Infarction.
    Wiley BM; Eckman PM; Jentzer JC
    Crit Care Med; 2021 May; 49(5):865-869. PubMed ID: 33854012
    [No Abstract]   [Full Text] [Related]  

  • 78. Management of shock in acute myocardial infarction.
    Pema PJ
    J Am Osteopath Assoc; 1971 Mar; 70(7):692-702. PubMed ID: 4926966
    [No Abstract]   [Full Text] [Related]  

  • 79. [Cardiogenic shock caused by right ventricular infarction--new perspective for the use of hypertonic solutions].
    Serrano Júnior CV; Ramires JA
    Arq Bras Cardiol; 1991 Dec; 57(6):433-4. PubMed ID: 1824214
    [No Abstract]   [Full Text] [Related]  

  • 80. [Digitalis and myocardial infarct].
    Heikkilä J
    Duodecim; 1974; 90(7):388-401. PubMed ID: 4603477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.